Clinical Trial Update: The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy [Phase 2, Phase 3]

View source ↗

Summary

An update indicating that the oral DLBS1033 study in diabetic polyneuropathy is currently not recruiting for Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Polyneuropathy
• Peripheral Nervous System Diseases
• Peripheral Neuropathy

Drugs mentioned

• DLBS1033 (DLBS1033)

Snippet

Sponsor: Universitas Sebelas Maret | Conditions: Diabetic Polyneuropathy, Peripheral Nervous System Diseases | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING